Exelixis
EXEL
#1679
Rank
$13.09 B
Marketcap
$52.10
Share price
-1.70%
Change (1 day)
24.79%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company